Paper974986
Ten-year results of the treatment of primary operable breast carcinoma: A summary of 304 patients evaluated by the TNM system.
Schottenfeld D and 3 others. Cancer, 1976. Cited by 121 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Ten-year results of the treatment of primary operable breast carcinoma: A summary of 304 patients evaluated by the TNM system. Papers, record 974986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/974986
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ten-year results of the treatment of primary operable breast carcinoma: A summary of 304 patients evaluated by the TNM system.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Carcinoma | Major topic |
| Evaluation Studies as Topic | |
| Female | |
| Humans | |
| Lymphatic Metastasis | |
| Middle Aged | |
| Neoplasm Metastasis | |
| Time Factors |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 121 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 25,759,625 | Prognostic Factors in Operated Stage IIIC, Pathological N3a Breast Cancer Patients. | Breast Care (Basel) | 2014 | https://conductscience.org/library/papers/25759625 | PubMed |
| 20,931,014 | NEO adjuvant chemotherapy in breast cancer: What have we learned so far? | Indian J Med Paediatr Oncol | 2010 | https://conductscience.org/library/papers/20931014 | PubMed |
| 16,142,429 | Nerve-sparing axillary dissection using the da Vinci Surgical System. | World J Surg | 2005 | https://conductscience.org/library/papers/16142429 | PubMed |
| 9,712,568 | Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. | Ann Surg | 1998 | https://conductscience.org/library/papers/9712568 | PubMed |
| 8,968,695 | A risk-benefit assessment of anthracycline antibiotics in antineoplastic therapy. | Drug Saf | 1996 | https://conductscience.org/library/papers/8968695 | PubMed |
| 7,865,951 | Conservation surgery for breast cancer: selection criteria and technical considerations. | Surg Today | 1994 | https://conductscience.org/library/papers/7865951 | PubMed |
| 7,556,307 | The use of technetium-99m sestamibi to indicate breast cancer invasiveness. | Eur J Nucl Med | 1995 | https://conductscience.org/library/papers/7556307 | PubMed |
| 7,496,835 | Improved survival in young women with breast cancer. | Ann Surg Oncol | 1995 | https://conductscience.org/library/papers/7496835 | PubMed |
| 7,177,763 | Major stimulus dimensions determining detection of simulated breast lesions. | Percept Psychophys | 1982 | https://conductscience.org/library/papers/7177763 | PubMed |
| 6,880,183 | Irradiation as an alternative to mastectomy for early breast cancer. | West J Med | 1983 | https://conductscience.org/library/papers/6880183 | PubMed |
| 6,696,528 | Breast carcinoma in women 35 years of age or younger. | Ann Surg | 1984 | https://conductscience.org/library/papers/6696528 | PubMed |
| 3,801,277 | A suggested follow-up time for breast cancer patients. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3801277 | PubMed |
| 1,627,815 | Prognostic factors in node-positive operable breast cancer patients receiving adjuvant chemotherapy. | Breast Cancer Res Treat | 1992 | https://conductscience.org/library/papers/1627815 | PubMed |
| 1,319,699 | Current management of male breast cancer. A review of 104 cases. | Ann Surg | 1992 | https://conductscience.org/library/papers/1319699 | PubMed |
| 728,351 | Survival and recurrences five years after selective treatment for breast carcinoma. | Br J Cancer | 1978 | https://conductscience.org/library/papers/728351 | PubMed |
| 650,646 | Clinical study of recurrence rate and survival time of patients with carcinoma of the breast treated by biopsy excision without any other therapy. | J R Soc Med | 1978 | https://conductscience.org/library/papers/650646 | PubMed |
| 497,947 | Five-year survival of women with breast cancer in northern Alberta. | Can Med Assoc J | 1979 | https://conductscience.org/library/papers/497947 | PubMed |
| 208,472 | Male breast cancer: a clinicopathologic study of 97 cases. | Ann Surg | 1978 | https://conductscience.org/library/papers/208472 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TENM1 | 10,178 | PubTator's text mining | https://conductscience.org/library/genes/10178 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/974986
GET https://conductscience.org/api/papers/v1/974986/authors